A machine learning model found that background parenchymal enhancement (BPE) on breast MRI is an indicator of breast cancer risk in women with extremely dense breasts.
With the recent recommendation changes from the European Council in 2022, how radiologists screen for breast cancer is changing. Mammography has long been an essential technology in screening for breast cancer, and in the recommendations the Council formally recognized the advantages of digital breast tomosynthesis (DBT). This landmark acknowledges the research on and benefits of DBT, advocating…
A new study suggests that deep learning–based computer-aided diagnosis (CAD) for breast lesion classification on ultrasound can significantly improve radiologists' diagnostic performance.
Ultrasound is an effective standalone diagnostic method in patients with focal breast complaints, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA). Focal breast complaints can refer to pain, lumps, nipple discharge or other symptoms and conditions confined to a specific area of the breast.
In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.
Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a new study.
Women with high-risk breast lesions (HRLs) and no family history of breast cancer or BRCA mutations are generally considered to be at moderate risk of developing breast cancer. Breast cancer screening guidelines suggest breast MRI be considered as a supplement to mammography. But is this expensive exam necessary?
Cancer – one word that turns the patients’ world upside down. In addition to uncertainty and fear, they often face an unnerving series of exams and treatments. With its new One-Stop Clinic concept, GE Healthcare now wants to help make this journey as smooth as possible. At a single location, in an environment designed for comfort, the patients undergo all necessary steps within a short period…
In MRI-based monitoring of silicone implants, separation of silicone and fat tissue is challenging. A newly developed algorithm was designed to assist in the task.
Contrast-enhanced mammography (CEM) has gone a long way since it was first approved by the Food and Drug Administration (FDA) in 2011. An Italian expert explained how useful the modality has become in breast imaging in a dedicated course at ECR 2022.
Using functional MRI with inhaled xenon gas, researchers have identified that long COVID symptoms are related to microscopic abnormalities that affect how oxygen is exchanged from the lungs to the red blood cells.
Physicians use AI-powered technology for faster and earlier detection of diseases. At ECR Overture, Dr Steven Schalekamp, PhD, discussed the application of AI for chest radiography in paediatrics.
Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI.
Incorporating AI support into clinical practice can reduce repetitive tasks, saving approximately one hour of chest CT interpretation time in a radiologist’s typical workday.
Synthetic correlated diffusion makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time.
A software based on deep learning with convolutional neural networks can accurately and consistently classify breast density on mammograms according to BI-RADS criteria.
Groundbreaking technologies have improved our ability to accurately diagnose breast cancer and reduce callbacks, focusing on compassionate care for patients as they move along their breast health journey.
When it comes to your patient’s health, certainty matters. Breast biopsies play a vital role in the continuum of care for women, providing insights into mass and calcification identification so you can make the best-informed decisions.
Intrauterine contraceptive devices (IUDs) appear to have systemic effects on the body like those of hormone replacement therapy, according to a breast MRI study being presented at the annual meeting of the Radiological Society of North America (RSNA).
